Alzheimer’s disease is characterized by more low-density erythrocytes with increased volume and enhanced β-amyloid x-40 content

Authors


  • P. Järemo and M. Milovanovic contributed equally to the work.

Petter Järemo, MD, PhD, Department of Internal Medicine, The Vrinnevi Hospital, S-601 82 Norrköping, Sweden. (fax: +4611125662; email: petter.jaremo@beta.telenordia.se).

Ancillary